Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

Louise J. Young, Nicholas S. Wilson, Petra Schnorrer, Adele Mount, Rachel J. Lundie, Nicole L. La Gruta, Brendan S. Crabb, Abrielle T. Belz, William R. Heath, Jose A. Villadangos

Research output: Contribution to journalArticleResearchpeer-review

55 Citations (Scopus)

Abstract

When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II-peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.

Original languageEnglish
Pages (from-to)17753-17758
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number45
DOIs
Publication statusPublished - 6 Nov 2007

Keywords

  • Adjuvants
  • Antigen presentation
  • Endocytosis
  • Immunosuppression
  • Immunotherapy

Cite this

Young, Louise J. ; Wilson, Nicholas S. ; Schnorrer, Petra ; Mount, Adele ; Lundie, Rachel J. ; La Gruta, Nicole L. ; Crabb, Brendan S. ; Belz, Abrielle T. ; Heath, William R. ; Villadangos, Jose A. / Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 45. pp. 17753-17758.
@article{0341e00f4da841638b7695090256fe44,
title = "Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens",
abstract = "When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II-peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.",
keywords = "Adjuvants, Antigen presentation, Endocytosis, Immunosuppression, Immunotherapy",
author = "Young, {Louise J.} and Wilson, {Nicholas S.} and Petra Schnorrer and Adele Mount and Lundie, {Rachel J.} and {La Gruta}, {Nicole L.} and Crabb, {Brendan S.} and Belz, {Abrielle T.} and Heath, {William R.} and Villadangos, {Jose A.}",
year = "2007",
month = "11",
day = "6",
doi = "10.1073/pnas.0708622104",
language = "English",
volume = "104",
pages = "17753--17758",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "45",

}

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. / Young, Louise J.; Wilson, Nicholas S.; Schnorrer, Petra; Mount, Adele; Lundie, Rachel J.; La Gruta, Nicole L.; Crabb, Brendan S.; Belz, Abrielle T.; Heath, William R.; Villadangos, Jose A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 45, 06.11.2007, p. 17753-17758.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

AU - Young, Louise J.

AU - Wilson, Nicholas S.

AU - Schnorrer, Petra

AU - Mount, Adele

AU - Lundie, Rachel J.

AU - La Gruta, Nicole L.

AU - Crabb, Brendan S.

AU - Belz, Abrielle T.

AU - Heath, William R.

AU - Villadangos, Jose A.

PY - 2007/11/6

Y1 - 2007/11/6

N2 - When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II-peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.

AB - When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II-peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.

KW - Adjuvants

KW - Antigen presentation

KW - Endocytosis

KW - Immunosuppression

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=36749054067&partnerID=8YFLogxK

U2 - 10.1073/pnas.0708622104

DO - 10.1073/pnas.0708622104

M3 - Article

C2 - 17978177

AN - SCOPUS:36749054067

VL - 104

SP - 17753

EP - 17758

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 45

ER -